Tom Yeung here with your Sunday Digest. In the 1990s, my father moved our family to a new overseas “Florida-style” housing development.
CME Group's Q1 results reflect improved revenues and increased volatility that aided volumes.
CME Group Inc. Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Company Participants Adam Minick - Investor Relations Terry Duffy - Chairman & Chief Executive Officer Suzanne Sprague - Chief Operating Officer & Head, Risk and Clearing Sunil Cutinho - Chief Information Officer Lynne Fitzpatrick - Chief Financial Officer Derek Sammann - Global Head, Commodities Julie Winkler - Chief Commercial Officer Mike Dennis - Global Head, Fixed Income Conference Call Participants Kyle Voigt - KBW Dan Fannon - Jefferies Patrick Moley - Piper Sandler Ken Worthington - JP Morgan Ben Budish - Barclays Capital Bill Katz - TD Cowen Owen Lau - Oppenheimer Alex Kramm - UBS Craig Siegenthaler - Bank of America Brian Bedell - Deutsche Bank Alex Blostein - Goldman Sachs Ashish Sabadra - RBC Capital Markets Chris Allen - Citi Simon Clinch - Redburn Atlantic Operator Welcome to the CME Group First Quarter 2025 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.
The headline numbers for CME (CME) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $2.50 per share a year ago.
CME's first-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
Besides Wall Street's top -and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
The 60/40 portfolio used to be a rock-solid strategy. But persistent inflation and bond market volatility have turned the "safe" 40% into a real risk. I'm not a fan of bonds—and with good reason. I'd rather own high-quality businesses with dependable dividends and stronger long-term return potential. In this article, I highlight three stable, income-focused stocks I'd buy without hesitation to reduce portfolio risk and potentially outperform the 60/40 crowd.
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JWN, EXE and CME are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is how CME Group (CME) and British Land Company PLC Sponsored ADR (BTLCY) have performed compared to their sector so far this year.